Category Archives: Pharma & Biotech

Pharma & Biotech Press Releases & News distributed via EuropaWire

Kuehne+Nagel’s subsidiary QuickSTAT opens new control tower in Singapore for time-critical clinical trial logistics

(PRESS RELEASE) SINGAPORE, 22-Jul-2021 — /EuropaWire/ — Kuehne+Nagel, one of the world’s leading logistics companies, has announced that its subsidiary QuickSTAT has opened a new control tower and conditioning facility in Singapore. The investment is part of Kuehne+Nagel and QuickSTAT’s … Read the full press release

Drugs for Neglected Diseases initiative: first all-oral treatment for Human African trypanosomiasis (sleeping sickness) gets US Food and Drug Administration (FDA) approval

(PRESS RELEASE) PARIS, 20-Jul-2021 — /EuropaWire/ — Sanofi (EPA: SAN), a global biopharmaceutical company focused on human health, has announced fexinidazole approval by the US Food and Drug Administration (FDA) as the first all-oral treatment for both stages of the … Read the full press release

Merck and Inbrain Neuroelectronics to collaborate on next generation of graphene-based bioelectronic therapies for targeted treatment of chronic diseases

Innovation Center project of Merck aims to develop smart neurostimulators for targeted treatment of chronic diseases Second collaboration within the Bioelectronics innovation field of Merck focuses on increasing the selectivity and power efficiency of the device to enable energy intensive … Read the full press release

Cure for prostate cancer on the horizon

(PRESS RELEASE) FREIBURG, Germany, 1-Jul-2021 — /EuropaWire/ — Prostate cancer is the second most common cancer. According to the American Cancer Association, 1 in every 8 men will be diagnosed with it in their lifetime. In 2018 around 1.2 million … Read the full press release

BASF obtains crucial standards for food and feed industry for its crude glycerin production at the Dusseldorf-Holthausen site

Important standards for the food and feed industry Quality, traceability and safety along the complete production chain (PRESS RELEASE) LUDWIGSHAFEN, 14-Jun-2021 — /EuropaWire/ — German multinational chemical company BASF announces that it has obtained GMP+ and ISO 22000 certifications for … Read the full press release

De zelflerende algoritme DBLG1®: eenvoudig te gebruiken voor een optimale en gepersonaliseerde behandeling van diabetes type 1

(PRESS RELEASE) PARIJS, 2-Jun-2021 — /EuropaWire/ — Vanaf het begin heeft Diabeloop innovatieve systemen ontwikkeld om de behandeling van diabetes type 1 te automatiseren en te personaliseren, waarbij altijd rekening wordt gehouden met de optiek van de patiënt. Het Franse … Read the full press release

European Society of Cardiology to hold annual EuroCMR congress on 6 to 8 May online

(PRESS RELEASE) SOPHIA ANTIPOLIS CEDEX, France, 12-Apr-2021 — /EuropaWire/ — EuroCMR 2021 will highlight how magnetic resonance imaging (MRI) of the heart helps physicians pinpoint diagnoses and tailor treatment. EuroCMR 2021 will take place on 6 to 8 May online. … Read the full press release

Sanofi launches more impactful Corporate Social Responsibility (CSR) strategy

Accelerating projects on access to medicines, support for vulnerable communities, environmental conservation, and diversity and inclusion Creation of Sanofi Global Health, global nonprofit unit to provide 40 of the world’s poorest countries access to 30 essential medicines (PRESS RELEASE) PARIS, 7-Apr-2021 — … Read the full press release

Largest Supply Chain for Face masks, FFP2, FFP3 and cloth masks

Creative Concepts Manufacturing Group Unveils its innovative 5-Layer Nano-PTFE Filtering Technology Reusable and Washable Cloth Mask for everyday civilians – AirGuard™ Face Mask (PRESS RELEASE) BOLOGNA, 31-Mar-2021 — /EuropaWire/ — Creative Concepts Manufacturing Group announces campaign launch of their new … Read the full press release

Novartis welcomes new Chief Legal Officer Karen L. Hale

(PRESS RELEASE) BASEL, 22-Mar-2021 — /EuropaWire/ — Swiss multinational pharmaceutical Novartis appoints Karen L. Hale as Chief Legal Officer. She succeeds Shannon Klinger. Karen will be based in Basel, Switzerland and will join the Executive Committee of Novartis (ECN) and … Read the full press release

Covestro’s new polycarbonates supports the advancement of drug delivery devices and surgical instruments

(PRESS RELEASE) LEVERKUSEN, 16-Mar-2021 — /EuropaWire/ — Covestro announces new polycarbonates for development of drug delivery devices and surgical instruments. Covestro offers two new families of the polycarbonate Makrolon®: improved low-friction types and maximum strength glass-filled products. The latter are also … Read the full press release

FB Vision and Bausch+Lomb enter into multi-country commercial agreement to commercialize Ozodrop™ Eye Drops

(PRESS RELEASE) SAN BENEDETTO DEL TRONTO, Italy, 15-Mar-2021 — /EuropaWire/ — FB Vision, an Italian joint stock company specialized in ophthalmics, announced a partnership with Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc., to … Read the full press release

Thomas Leysen appointed Chairman of DSM Supervisory Board

(PRESS RELEASE) HEERLEN, 4-Mar-2021 — /EuropaWire/ — Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, announces the retirement of Rob Routs as Chairman and member of the DSM Supervisory Board at the close of the Annual … Read the full press release

Kuehne+Nagel strengthens its presence in pharma and healthcare logistics in China through partnership with Jointown

Extensive cooperation across warehousing, domestic distribution, international transports and logistics In support of Chinese pharma customers’ access to international markets, leveraging Kuehne+Nagel’s global pharma network (PRESS RELEASE) SHANGHAI, China, 24-Feb-2021 — /EuropaWire/ — Global transport and logistics leader Kuehne+Nagel announces … Read the full press release

A URSAPHARM Arzneimittel e a CEBINA anunciam uma parceria com vista a reaproveitar o anti-histamínico azelastina para combater a COVID-19

URSAPHARM Arzneimittel and CEBINA announce partnership to repurpose the antihistamine azelastine to combat COVID-19

(PRESS RELEASE) SAARBRÜCKEN / VIENA, 17-Feb-2021 — /EuropaWire/ — Na luta contra o vírus SARS-CoV-2, um grande número de empresas farmacêuticas está em busca de novas abordagens para combater a pandemia. Além das vacinas, estão a ser feitos esforços intensivos … Read the full press release

URSAPHARM Arzneimittel et CEBINA annoncent un partenariat pour reconvertir l’antihistaminique azélastine afin de lutter contre la COVID-19

URSAPHARM Arzneimittel and CEBINA announce partnership to repurpose the antihistamine azelastine to combat COVID-19

(PRESS RELEASE) SARREBRUCK / VIENNE, 17-Feb-2021 — /EuropaWire/ — Dans la lutte contre le virus SRAS-CoV-2, un grand nombre d’entreprises pharmaceutiques recherchent de nouvelles approches pour combattre la pandémie. Outre les vaccins, des efforts intensifs de recherche et développement à … Read the full press release

URSAPHARM Arzneimittel y CEBINA anuncian una colaboración para readaptar el antihistamínico azelastine para combatir la COVID-19

URSAPHARM Arzneimittel and CEBINA announce partnership to repurpose the antihistamine azelastine to combat COVID-19

(PRESS RELEASE) SAARBRÜCKEN / VIENA, 17-Feb-2021 — /EuropaWire/ — En la lucha contra el virus SARS-CoV-2, una gran cantidad de empresas farmacéuticas están buscando nuevos enfoques para combatir la pandemia. Además de las vacunas, las iniciativas exhaustivas de investigación y … Read the full press release

URSAPHARM Arzneimittel and CEBINA announce partnership to repurpose the antihistamine azelastine to combat COVID-19

URSAPHARM Arzneimittel and CEBINA announce partnership to repurpose the antihistamine azelastine to combat COVID-19

(PRESS RELEASE) SAARBRÜCKEN / VIENNA, 17-Feb-2021 — /EuropaWire/ — In the fight against the SARS-CoV-2 virus, a large number of pharmaceutical companies are looking for new approaches to combat the pandemic. In addition to vaccines, intensive research and development efforts … Read the full press release

DHL Global Forwarding plays important role in COVID-19 vaccine distribution in Japan

DHL Global Forwarding contracted for vaccine distribution to Japan First successful delivery to Japan completed end of last week Pharma freezers at DHL facility in Japan ensure vaccine is stored at -70 degrees until final delivery (PRESS RELEASE) BONN, 15-Feb-2021 … Read the full press release

Lundbeck commits to become carbon neutral across the entire value chain by 2050

(PRESS RELEASE) COPENHAGEN, 4-Feb-2021 — /EuropaWire/ — Danish international pharmaceutical company H. Lundbeck A/S (Lundbeck) announces its new 15-year climate target, which includes a detailed action plan to reduce emissions, approved by the Science Based Targets initiative (SBTi), towards becoming … Read the full press release

COVID-19 Vaccine AstraZeneca confirmed safe and effective at preventing COVID-19

Increased efficacy with longer inter-dose interval Protection of over 70% starting after a first dose First indication of reduction in disease transmission of up to 67% (PRESS RELEASE) CAMBRIDGE, 3-Feb-2021 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), a British–Swedish multinational pharmaceutical … Read the full press release

Genetic diversity: GSK and Novartis launch Project Africa GRADIENT to optimise treatment responses for malaria and tuberculosis in Africa

Project Africa GRADIENT calls on local researchers to submit proposals exploring the link between genetic diversity and response to malaria and tuberculosis drugs in African patients. Combined funding commitment of GBP 2.8 million (USD 3.6 million) over five years. Researchers … Read the full press release

Sanofi gains full global rights to a promising antibody for inflammatory disorders with the acquisition of Kymab

(PRESS RELEASE) PARIS/ CAMBRIDGE, 11-Jan-2021 — /EuropaWire/ — French multinational pharmaceutical company Sanofi to acquire Kymab, a clinical-stage biopharmaceutical company developing fully human monoclonal antibodies with a focus on immune-mediated diseases and immuno-oncology therapeutics. The agreement includes an upfront payment … Read the full press release

QIAGEN appoints Dr. Toralf Haag as a member of the Supervisory Board and the Audit Committee

(PRESS RELEASE) VENLO, the Netherlands, 8-Jan-2021 — /EuropaWire/ — QIAGEN announces the appointment of Dr. Toralf Haag as a member of the Supervisory Board with immediate effect. He will also become a member of the Audit Committee. Dr. Haag was … Read the full press release

Kuehne+Nagel takes responsibility of global distribution of Covid-19 Vaccine Moderna

New arrangement leverages Kuehne+Nagel’s global solutions for pharma & healthcare logistics (PRESS RELEASE) CAMBRIDGE, MA, U.S.A. / SCHINDELLEGI, 7-Jan-2021 — /EuropaWire/ — Global transport and logistics company Kuehne+Nagel announces international supply chain arrangement with Moderna, Inc. (NASDAQ:MRNA), a biotechnology company … Read the full press release

Lundbeck welcomes acceptance of Vyepti’s marketing authorization application by the European Medicines Agency for the prevention of migraine

(PRESS RELEASE) VALBY, Denmark, 22-Dec-2020 — /EuropaWire/ — Danish international pharmaceutical company, H. Lundbeck A/S (Lundbeck) announces that its marketing authorization application for Vyepti™ (eptinezumab-jjmr) has been accepted by the European Medicines Agency (EMA). The filing seeks approval to introduce … Read the full press release

Aimmune Therapeutics’ PALFORZIA the first-ever treatment option approved for peanut allergy in the EU

(PRESS RELEASE) VEVEY, 21-Dec-2020 — /EuropaWire/ — Nestlé Health Science Company, Aimmune Therapeutics announces that PALFORZIA® [defatted powder of Arachis hypogaea L., semen (peanuts)], has been approved by the European Commission for the treatment of peanut allergy in the European … Read the full press release

OHMX.bio and Fujirebio Europe to develop clinical in vitro diagnostics platform incorporating third generation sequencing technologies

IVD-seq project received 720K EURO research grant from Flanders Innovation & Entrepreneurship (VLAIO) (PRESS RELEASE) GENT, 8-Dec-2020 — /EuropaWire/ — Fujirebio Europe announces that together with its partner OHMX.bio, a provider of cutting-edge “omics” solutions, have been awarded a 720K … Read the full press release

EIB signs €15.0 million financing deal with AB Science to support the development of masitinib as a treatment for COVID-19

Financing deal worth €15.0 million signed to support clinical development programme for masitinib Masitinib developed as a credible candidate for treating COVID-19 in addition to other diseases for which no therapeutic solutions are available (PRESS RELEASE) PARIS, 30-Nov-2020 — /EuropaWire/ — … Read the full press release

Novozymes welcomes new Executive Vice President of People, Sustainability & Brand Morten Enggaard Rasmussen

(PRESS RELEASE) COPENHAGEN, 26-Nov-2020 — /EuropaWire/ — Global biotechnology company Novozymes announces the appointment of Morten Enggaard Rasmussen as Executive Vice President of People, Sustainability & Brand succeeding Thomas Videbæk. Morten will take up his new position on 1 April, … Read the full press release